Admission to Trading (XS3408975012, SPUK 124)
Canadian Imperial Bank of Commerce
14 August 2026
Admission to Trading
14 August 2026
Canadian Imperial Bank of Commerce (LEI: 2IGI19DL77OX0HC3ZE78) ("CIBC" and the "Issuer"), announces that the following transferable securities have been admitted to trading on 14 August 2026 on the London Stock Exchange's main market:
The Issuer's GBP 1,315,751 Preference Share Linked Notes due August 2032 (XS3408975012, SPUK 124) issued under the Issuer's Structured Note Programme (the "Notes").
Full information on the Issuer and the offer of the Notes is only available on the basis of the base prospectus dated 23 January 2026 (the "Base Prospectus") and any supplements thereto, read together with the final terms published by the Issuer on 5 August 2026 (the Final Terms).
The Base Prospectus and the Final Terms have been published on the website of the London Stock Exchange through a regulatory information service (http://www.londonstockexchange.com/exchange/news/market-news/market-news-home.html). The Base Prospectus and the Final Terms will be available on the website of the Issuer CIBC Investor Relations.
A copy of each of the Base Prospectus and the Final Terms have also been submitted to the National Storage Mechanism and are available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
For further information please contact
Canadian Imperial Bank of Commerce
81 Bay St.
Canada Square
Toronto, Ontario
Canada M5J 0E7
Attention: Execution Management, London (email: dlcibcexecutionmanagement@cibc.com)
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Final Terms and the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and the Base Prospectus is not addressed. Prior to relying on the information contained in the Final Terms and the Base Prospectus you must ascertain from the Final Terms and the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.
This publication does not constitute an offering of the Notes described in the Final Terms for sale in the United States. This is not for distribution in the United States. The Notes have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "Securities Act") and are subject to U.S. tax law requirements. Subject to certain exceptions, Notes may not be offered, sold or delivered within the United States or to, or for the account or benefit of U.S. persons, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the Notes in the United States.
Your right to access this service is conditional upon complying with the above requirement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.